Arcus Biosciences (RCUS) Asset Utilization Ratio (2018 - 2026)

Arcus Biosciences' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.22 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 84.14% year-over-year to 0.22; the TTM figure through Mar 2026 stood at 0.22 (up 84.14% YoY), while the FY2025 annual figure was 0.22, down 6.1% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.22, down from 0.23 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.3 in Q3 2022, with the low at 0.08 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 0.2 (2024), against an average of 0.18.
• Peak annual rise in Asset Utilization Ratio reached 591.67% in 2022, while the deepest fall reached 73.61% in 2022.
• Arcus Biosciences' Asset Utilization Ratio stood at 0.08 in 2022, then increased by 5.21% to 0.09 in 2023, then surged by 140.73% to 0.21 in 2024, then gained by 11.01% to 0.23 in 2025, then fell by 5.48% to 0.22 in 2026.
• Business Quant data shows RCUS's Asset Utilization Ratio at 0.22 in Q1 2026, 0.23 in Q4 2025, and 0.23 in Q3 2025.